BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 20638287)

  • 1. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
    Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
    Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
    Bandgar BP; Gawande SS
    Bioorg Med Chem; 2010 Mar; 18(5):2060-5. PubMed ID: 20138527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents.
    Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN
    Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 3,5-diaryl-4,5-dihydro-1H-pyrazoles as new tyrosinase inhibitors.
    Zhou Z; Zhuo J; Yan S; Ma L
    Bioorg Med Chem; 2013 Apr; 21(7):2156-62. PubMed ID: 23391365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells.
    Ha YM; Park JY; Park YJ; Park D; Choi YJ; Kim JM; Lee EK; Han YK; Kim JA; Lee JY; Moon HR; Chung HY
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2445-9. PubMed ID: 21397499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2-c]pyrazole derivatives as new anticancer agents.
    Chou LC; Huang LJ; Hsu MH; Fang MC; Yang JS; Zhuang SH; Lin HY; Lee FY; Teng CM; Kuo SC
    Eur J Med Chem; 2010 Apr; 45(4):1395-402. PubMed ID: 20097456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new heterocyclic hybrids based on pyrazole and thiazolidinone scaffolds as potent inhibitors of tyrosinase.
    Gawande SS; Warangkar SC; Bandgar BP; Khobragade CN
    Bioorg Med Chem; 2013 May; 21(10):2772-7. PubMed ID: 23566759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
    Insuasty B; Tigreros A; Orozco F; Quiroga J; AbonĂ­a R; Nogueras M; Sanchez A; Cobo J
    Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new pyrazole derivatives and their anticancer evaluation.
    Nitulescu GM; Draghici C; Missir AV
    Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents.
    Bano S; Javed K; Ahmad S; Rathish IG; Singh S; Alam MS
    Eur J Med Chem; 2011 Dec; 46(12):5763-8. PubMed ID: 22019186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives.
    Kumar V; Madaan A; Sanna VK; Vishnoi M; Joshi N; Singh AT; Jaggi M; Sharma PK; Irchhaiya R; Burman AC
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1169-78. PubMed ID: 19555167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity.
    El-Deeb IM; Lee SH
    Bioorg Med Chem; 2010 Jun; 18(11):3961-73. PubMed ID: 20472440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, antiamoebic activity and cytotoxicity of new pyrazolo[3, 4-d]pyrimidine-6-one derivatives.
    Hayat F; Salahuddin A; Azam A
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):472-9. PubMed ID: 21054147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
    Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
    Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
    Zheng LW; Zhu J; Zhao BX; Huang YH; Ding J; Miao JY
    Eur J Med Chem; 2010 Dec; 45(12):5792-9. PubMed ID: 20947221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives.
    Zhang D; Wang G; Zhao G; Xu W; Huo L
    Eur J Med Chem; 2011 Dec; 46(12):5868-77. PubMed ID: 22000925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.
    Lv PC; Wang KR; Li QS; Chen J; Sun J; Zhu HL
    Bioorg Med Chem; 2010 Feb; 18(3):1117-23. PubMed ID: 20056425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,5-Diaryl-1H-pyrazole as a molecular scaffold for the synthesis of apoptosis-inducing agents.
    Shaw AY; Liau HH; Lu PJ; Yang CN; Lee CH; Chen JY; Xu Z; Flynn G
    Bioorg Med Chem; 2010 May; 18(9):3270-8. PubMed ID: 20381360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
    Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
    Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
    Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.